Lemaitre Vascular (LMAT) Depreciation & Amortization (CF) (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 2.78% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $10.5 million (up 7.27% YoY), while the FY2025 annual figure was $10.4 million, up 8.43% from the prior year.
• Depreciation & Amortization (CF) climbed to $2.6 million in Q1 2026 per LMAT's latest filing, from $2.6 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $2.6 million in Q2 2025 and bottomed at $2.3 million in Q4 2022.
• Historically, Depreciation & Amortization (CF) has averaged $2.4 million across 5 years, with a median of $2.4 million in 2024.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) fell 20.67% — and 2025, when it gained 11.07%.
• Lemaitre Vascular's Depreciation & Amortization (CF) stood at $2.3 million in 2022, then grew by 6.77% to $2.4 million in 2023, then declined by 1.11% to $2.4 million in 2024, then increased by 7.82% to $2.6 million in 2025, then grew by 0.69% to $2.6 million in 2026.
• Business Quant data shows LMAT's Depreciation & Amortization (CF) at $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.